BioSig Technologies: FDA Clears the Investigational New Drug Application to Enable the Phase II Trial of ViralClear's Merimepodib, Oral Solution to Treat Adult Patients with Advanced COVID-19, to Proceed

Press/Media: Expert Comment

PeriodMay 18 2020

Media coverage

1

Media coverage

  • TitleBioSig Technologies: FDA Clears the Investigational New Drug Application to Enable the Phase II Trial of ViralClear's Merimepodib, Oral Solution to Treat Adult Patients with Advanced COVID-19, to Proceed
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date5/18/20
    PersonsSlobodan Paessler, Cheng Huang, John Manning